FIELD: medicine. SUBSTANCE: proposed preparation is used in adults and children as a component of infusion therapy by intravenous route. Daily dose for adults and children is 5-20 and 5-10 mg/kg, respectively, for 3-5 days. Preparation is an aqueous solution of salts: sodium chloride, potassium chloride, calcium chloride, magnesium chloride and sodium acetate. Preparation is used for correction of an aqueous-electrolyte balance and metabolic acidosis. EFFECT: enhanced effectiveness of agent proposed.
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION OF HEMODYNAMIC ACTION WITH THE FUNCTION FOR NORMALIZATION OF ACID-BASE BALANCE AND ELECTROLYTE ONE | 2000 |
|
RU2185173C2 |
| INFUSION SOLUTION FOR TOTAL BLOOD VOLUME REPLACEMENT, HYDRO-ELECTROLYTIC REBALANCING AND HEMATOPOIESIS PROCESS NORMALISATION | 2009 |
|
RU2423987C1 |
| PLASMA-ADAPTED BALANCED SOLUTION OF ELECTROLYTES | 2010 |
|
RU2550963C2 |
| ELECTROLYTE SALT SOLUTION FOR ENTERAL INFUSION | 2019 |
|
RU2699222C1 |
| PHYSIOLITE INFUSION SOLUTION | 2013 |
|
RU2533257C1 |
| MEDICINAL AGENT FOR TREATMENT OF CHILDREN OF THE FIRST WEEKS OF LIFE WITH GASTRODUODENAL PATHOLOGY | 1994 |
|
RU2054948C1 |
| MULTICOMPONENT INFUSION SOLUTION OF ELECTROLYTES IN COMBINATION WITH BIOLOGICALLY ACTIVE COMPONENTS FOR INTRAVENOUS ADMINISTRATION | 2022 |
|
RU2796724C1 |
| METHOD OF PREPARING PARENTERAL DRUG FOR STORAGE | 1998 |
|
RU2134565C1 |
| METHOD OF PREPARING PHARMACEUTICAL COMPOSITION SOLUTION BASED ON SUBSTANCE OF GENE ENGINEERING (RECOMBINANT) HUMAN INSULIN | 2001 |
|
RU2184533C1 |
| METHOD OF INSULIN PURIFICATION | 1999 |
|
RU2146944C1 |
